Dr. Taylor joined Vaxart in May 2018. Prior to joining Vaxart, Dr. Taylor served as a senior medical officer of the drug and vaccine global development programs at PATH in Seattle. Earlier, he was Medical Director of Vaccines at Takeda Vaccines, developing norovirus and dengue vaccines. Previously, Dr. Taylor served as Chief Medical Officer at VaxInnate Corporation, where he focused on the development of recombinant vaccines for influenza, and Chief Medical Officer at Salix Pharmaceuticals, where he developed rifaximin (Xifaxan) for the treatment of traveler’s diarrhea. Before Salix, he was a research professor for the Department of International Health at Johns Hopkins Bloomberg School of Public Health. Dr. Taylor began his career as an Epidemic Intelligence Service Officer in the Enteric Disease Branch at the U.S. Centers for Disease Control and Prevention (CDC) and served 22 years in various capacities at research institutes in the United States Army, including Founder and Chief of the Department of Clinical Trials in the Division of Communicable Diseases and Immunology at the Walter Reed Army Institute of Research. Dr. Taylor is board certified in internal medicine and infectious diseases. He earned his MSc. in medical parasitology from the London School of Hygiene and Tropical Medicine, M.D. from Harvard Medical School, D.M.S. from the Geisel School of Medicine at Dartmouth, and B.S. in biology from Kenyon College.